Hepatitis B virus reactivation with liver failure successfully treated with corticosteroids, foscarnet, and ganciclovir;Evolution favorable d'une reactivation du virus de l'hepatite B avec insuffisance hepatocellulaire grace a un traitement associant corticoides, foscarnet, et ganciclovir

Gastroenterologie Clinique et Biologique

Volumn 21, Issue 12, 1997, Pages 982-986

  Dumortier, Jérôme ^a   Durupt, Stéphane ^a   Chevallier, Michèle ^b   Trépo, Christian ^a,c   Zoulim, Fabien ^a,c  

^a HÔTEL DIEU   (France)

^b LMM Laboratoire Marcel Merieux   (France)

^c INSERM   (France)

Author keywords

Foscarnet; Ganciclovir; Hepatitis B virus; Liver failure; Reactivation; Treatment

Indexed keywords

CORTICOSTEROID; FOSCARNET; GANCICLOVIR; INTERFERON; PREDNISONE; ANTIVIRUS AGENT; GLUCOCORTICOID; METHYLPREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; DISEASE ACTIVITY; DRUG EFFICACY; FEMALE; HEPATITIS B; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER FAILURE; PATHOPHYSIOLOGY; DRUG COMBINATION; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HEPATITIS B VIRUS; VIRUS ACTIVATION;

ADULT; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; FEMALE; FOSCARNET; GANCICLOVIR; GLUCOCORTICOIDS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER FAILURE; METHYLPREDNISOLONE; VIRUS ACTIVATION;

EID: 0031313867     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Lévy P, Marcellin P, Martinot-Peignoux M, Degott C, Nataf J, Benhamou JP. Clinical course of spontaneous reactivation of hepatitis B virus infection in patients with chronic hepatitis B. Hepatology 1990;12:570-4.
2. Liaw YF, Yang SS, Chen TJ, Chu CM. Acute exacerbation in hepatitis Be antigen positive chronic type B hepatitis: a clinicopathological study. J Hepatol 1985;1:227-33.
3. Perrillo RP, Campbell CR, Sanders GE, Regenstein FG, Bodicky CJ. Spontaneous clearance and reactivation of hepatitis B virus infection among male homosexuals with chronic type B hepatitis. Ann Intern Med 1984;100:43-6.
4. Liaw YF, Tai DI, Chu CM, Pao CC, Chen TJ. Acute exacerbation in chronic type B hepatitis: comparison between HBeAg and antibody-positive patients. Hepatology 1987;7:20-3.
5. Davis GL, Hoofnagle JH, Waggoner JG. Spontaneous reactivation of chronic hepatitis B virus infection. Gastroenterology 1984;86:230-5.
6. Tong MJ, Sampliner RE, Govindarajan S, Co RL. Spontaneous reactivation of hepatitis B in chinese patients with HBsAg-positive chronic active hepatitis. Hepatology 1987;7:713-8.
7. Nair PV, Tong MJ, Stevenson D, Roskamp D, Boone C. A pilot study on the effects of prednisone withdrawal on serum hepatitis B virus DNA and HBeAg in chronic active hepatitis B. Hepatology 1986;6:1319-24.
8. Lau JYN, Lai CL, Lin HJ, Lok ASF, Liang RHS, Wu PC, et al. Fatal reactivation of chronic hepatitis B virus infection following withdrawal of chemotherapy in lymphoma patients. Q J Med 1989;270:911-7.
9. Lok ASF, Liang RHS, Chiu EKW, Wong KL, Chan TK, Todd D. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Gastroenterology 1991;100:182-8.
10. Nagington J, Cossart YE, Cohen BJ. Reactivation of hepatitis B after transplantation operations. Lancet 1977;1:558-60.
11. Dusheiko GM, Song E, Bowyer S, Whitcutt M, Maier G, Meyers A, et al. Natural history of hepatitis B virus infection in renal transplantation. A fifteen year follow up. Hepatology 1983;3:330-6.
12. Lai MY, Chen DS, Lee SC, Su IJ, Yang PM, Hsu HC, et al. Reactivation of hepatitis B virus in anti-HBe positive chronic active type B hepatitis: molecular and immunohistochemical studies. Hepatogastroenterology 1988;35:17-21.
13. Levin S, Hahn T. Interferon system in acute viral hepatitis. Lancet 1982;1:592-4.
14. Milazzo F, Gallo M, Fassio PG, Cargnel A, Fuglese A, Tovo PA, et al. Attempted treatment of fulminant viral hepatitis with human fibroblast interferon. Infection 1985;13:130-3.
15. Bismuth H, Samuel D, Gugenheim J, Castaing D, Bernuau J, Rueff B, et al. Emergency liver transplantation for fulminant hepatitis. Ann Intern Med 1987;107:337-41.
16. Zoulim F, Trepo C. Nucleoside analogs in the treatment of chronic viral hepatitis. Efficiency and complications. J Hepatol 1994;21:142-4.
17. Barrera P, Boerbooms AM, Van de Putte LB, Van der Meer JW. Effects of antirheumatic agents on cytokines. Semin Arthritis Rheum 1996;25:234-53.
18. Schaller H, Fischer M. Transcriptional control of hepadnavirus gene expression. In: Mason WS, Seeger C, eds. Current topics in microbiology and immunology. Hepadnaviruses. Molecular biology and pathogenesis. Berlin: Springer-Verlag, 1991: 41-60.
19. Angus P, Richards M, Bowden S, Ireton J, Sinclair R, Jones R, et al. Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infection. J Gastroenterol Hepatol 1993;8:353-7.
20. Singh N, Gayowski T. Lack of sustained efficacy of combination ganciclovir and foscarnet for hepatitis B virus recurrence after liver transplantation. Transplantation 1995;59:1629-30.
21. Locarnini S, Guo K, Lucas R, Gusl I. Inhibition of HBV DNA replication by ganciclovir in patients with AIDS. Lancet 1989;2:1225-6.
22. Bain VG, Daniels HM, Chans A, Alexander GJM, Williams R. Foscarnet therapy in chronic hepatitis B virus e antigen carriers. J Med Virol 1989;29:152-5.
23. Hedin G, Weiland O, Ljunggren K, Nordenfelt E, Hansson BG, Lernestedt JO, et al. Treatment with foscarnet of fulminant hepatitis B and fulminant hepatitis B and D coinfection. In: Zuckerman AJ, ed. Viral hepatitis and liver disease. New York: Alan R Liss Inc, 1988:947-52.
24. Zoulim F, Trépo C. Bénéfices et risques des traitements antiviraux prolongés: l'exemple de l'hépatite B chronique. Gastroenterol Clin Biol 1997;21:843-7.